Ceribell to Participate in Upcoming March Investor Conferences
Ceribell (Nasdaq: CBLL) will participate in two investor conferences in early March 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ceribell (Nasdaq: CBLL) will participate in two investor conferences in early March 2026. CFO Scott Blumberg will present at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026 at 1:00 p.m. PST / 4:00 p.m. EST.
CEO Jane Chao, Ph.D., and CFO Scott Blumberg will take part in a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 10:50 a.m. PST / 1:50 p.m. EST. Live and archived webcasts will be available in the company's Investor Relations section.
Details
News Market Reaction – CBLL
On Feb 19, the first trading day after this news, CBLL closed 1.81% above the previous close.
Data tracked by StockTitan Argus for the Feb 19 session.
Key Figures
- Raymond James conference date
- March 2, 2026
- Raymond James 47th Annual Institutional Investors Conference
- Raymond James presentation time
- 1:00 p.m. PST / 4:00 p.m. EST
- Ceribell CFO presentation slot
- TD Cowen conference date
- March 3, 2026
- TD Cowen 46th Annual Health Care Conference
- TD Cowen fireside chat time
- 10:50 a.m. PST / 1:50 p.m. EST
- Ceribell CEO and CFO fireside chat
Historical Context
-
Set date for Q4 and full-year 2025 results and webcast details.
-
FDA Breakthrough Device Designation for LVO stroke detection solution.
-
Announcement of presentation at J.P. Morgan Healthcare Conference.
-
FDA 510(k) clearance for first-of-its-kind delirium monitoring solution.
-
FDA 510(k) clearance for Clarity algorithm across neonatal to adult patients.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SUNNYVALE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced the company will be participating in two upcoming investor conferences. Scott Blumberg, CFO, will present at the upcoming Raymond James 47th Annual Institutional Investors Conference on Monday, March 2, 2026, at 1:00 p.m. Pacific Standard Time / 4:00 p.m. Eastern Standard Time. Jane Chao, Ph.D., CEO and Co-founder, and Scott Blumberg, CFO, will participate in a fireside chat at the upcoming TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:50 a.m. Pacific Standard Time / 1:50 p.m. Eastern Standard Time.
Event: Raymond James 47th Annual Institutional Investors Conference
Date: Monday, March 2, 2026
Time: 1:00 p.m. PST / 4:00 p.m. EST
Event: TD Cowen 46th Annual Health Care Conference
Date: Tuesday, March 3, 2026
Time: 10:50 a.m. PST / 1:50 p.m. EST
A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.
About CeriBell, Inc.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute-care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared for use in detecting seizure and delirium in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit www.ceribell.com or follow the company on LinkedIn.
Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com
Media Contact
Brian Price
Press@ceribell.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.